17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts

Cardiovasc Res. 2010 Mar 1;85(4):719-28. doi: 10.1093/cvr/cvp350. Epub 2009 Oct 27.

Abstract

Aims: Female sex and sex hormones contribute to cardiac remodelling. 17beta-estradiol (E2) is involved in the modulation of extracellular matrix composition and function. Here, we analysed the effect of E2 on matrix metalloproteinase (MMP)-2 gene expression and studied the underlying molecular mechanisms in rat cardiac fibroblasts and in a human fibroblast cell line.

Methods and results: In adult rat cardiac fibroblasts, E2 significantly decreased MMP-2 gene expression in an estrogen receptor (ER)-dependent manner. Transient transfection experiments of human MMP-2 (hMMP-2) promoter deletion constructs in a human fibroblast cell line revealed a regulatory region between -324 and -260 bp that is involved in E2/ERalpha-mediated repression of hMMP-2 gene transcription. Electrophoretic mobility shift assays (EMSA) and supershift analysis demonstrated the binding of transcription factor Elk-1 within this promoter region. Elk-1 was phosphorylated by E2 via the mitogen-activated protein kinase (MAPK) signalling pathway as shown by western blotting. Treatment of cells with the MAPK inhibitor PD98059 blocked the E2-dependent repression of hMMP-2 promoter activity as well as the endogenous MMP-2 mRNA levels in both human fibroblast cells and rat cardiac fibroblasts.

Conclusion: E2 inhibits MMP-2 expression via the ER and the MAPK pathway in rat cardiac fibroblasts and in a human fibroblast cell line. These mechanisms may contribute to sex-specific differences in fibrotic processes that are observed in human heart and other diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Estradiol / metabolism*
  • Estradiol / pharmacology
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism
  • Estrogens / metabolism*
  • Estrogens / pharmacology
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / enzymology
  • Female
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / physiology*
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / physiology
  • Humans
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Male
  • Matrix Metalloproteinase 2 / genetics*
  • Matrix Metalloproteinase Inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Myocardium / cytology*
  • Phosphorylation / drug effects
  • Phosphorylation / physiology
  • Promoter Regions, Genetic / physiology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / physiology
  • Ventricular Remodeling / physiology
  • ets-Domain Protein Elk-1 / metabolism

Substances

  • Estrogen Receptor alpha
  • Estrogens
  • Matrix Metalloproteinase Inhibitors
  • RNA, Messenger
  • ets-Domain Protein Elk-1
  • Estradiol
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Matrix Metalloproteinase 2